ArticleAME case reports2026

Severe radiodermatitis and implant loss associated with pembrolizumab and olaparib following pre-pectoral breast reconstruction in a 31-year-old female: a case report.

Jinyue Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.